Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q2 2023 Earnings

9MayConfirmed

Q3 2022

Q4 2022

Q1 2023

Q2 2023

0.47

0.56

0.65

0.74

Details

Expected EPS

0.47

Actual EPS

0.47

Surprise EPS

0

Surprise Percent

+0%

Description

Halozyme Therapeutics (HALO) has reported earnings of 0.47 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.